Biomaterial Database

Salivary IgA levels in atopic children. 1977

K Payette, and N S Weiss

Salivary IgA concentrations of 63 atopic and 60 non-atopic children were studied. Twenty-three children with a history of atopy who had not received immunotherapy had a significantly lower mean salivary IgA concentration than age-matched normal children. As a group, they may therefore be more vulnerable to respiratory infection.

UI	MeSH Term	Description	Entries
D006969	Hypersensitivity, Immediate	Hypersensitivity reactions which occur within minutes of exposure to challenging antigen due to the release of histamine which follows the antigen-antibody reaction and causes smooth muscle contraction and increased vascular permeability.	Atopic Hypersensitivity,Hypersensitivity, Atopic,Hypersensitivity, Type I,IgE-Mediated Hypersensitivity,Type I Hypersensitivity,Atopic Hypersensitivities,Hypersensitivities, Atopic,Hypersensitivities, IgE-Mediated,Hypersensitivities, Immediate,Hypersensitivities, Type I,Hypersensitivity, IgE-Mediated,IgE Mediated Hypersensitivity,IgE-Mediated Hypersensitivities,Immediate Hypersensitivities,Immediate Hypersensitivity,Type I Hypersensitivities
D007070	Immunoglobulin A	Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions.	IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007071	Immunoglobulin A, Secretory	The principle immunoglobulin in exocrine secretions such as milk, respiratory and intestinal mucin, saliva and tears. The complete molecule (around 400 kD) is composed of two four-chain units of IMMUNOGLOBULIN A, one SECRETORY COMPONENT and one J chain (IMMUNOGLOBULIN J-CHAINS).	Colostral IgA,IgA, Exocrine,IgA, Secretory,SIgA,Secretory IgA,Secretory Immunoglobulin A,Exocrine IgA,IgA, Colostral
D007167	Immunotherapy	Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection.	Immunotherapies
D008297	Male		Males
D002648	Child	A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL.	Children
D005260	Female		Females
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K Payette, and N S Weiss

Salivary IgA children with atopic diseases.

August 1971, Annals of allergy,

K Payette, and N S Weiss

Salivary IgA levels in normal children.

January 1986, Diagnostic immunology,

K Payette, and N S Weiss

The relationship between salivary IgA levels and dental caries in children.

January 2011, Journal of the Indian Society of Pedodontics and Preventive Dentistry,

K Payette, and N S Weiss

Oral mucosal status and salivary IgA levels of HIV-infected children.

October 2013, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology,

K Payette, and N S Weiss

IgA, IgG, IgM, and IgE levels in normal, healthy, non-atopic Israeli children.

October 1988, Annals of allergy,

K Payette, and N S Weiss

Measurement of salivary, urinary and fecal secretory IgA levels in children with partial or total IgA deficiency.

January 1994, Journal of investigational allergology & clinical immunology,

K Payette, and N S Weiss

Serum levels of immunoglobulin A (IgA) in atopic patients.

January 1968, Allergie und Asthma,

K Payette, and N S Weiss

Total salivary IgA, serum C3c and IgA in obese school children.

September 2002, The Journal of nutritional biochemistry,